You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|
|---|---|
| Published in |
New England Journal of Medicine, October 2016
|
| DOI | 10.1056/nejmoa1602252 |
| Pubmed ID | |
| Authors |
Robert L Ferris, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Lisa Licitra, Kevin Harrington, Stefan Kasper, Everett E Vokes, Caroline Even, Francis Worden, Nabil F Saba, Lara C Iglesias Docampo, Robert Haddad, Tamara Rordorf, Naomi Kiyota, Makoto Tahara, Manish Monga, Mark Lynch, William J Geese, Justin Kopit, James W Shaw, Maura L Gillison |
X Demographics
The data shown below were collected from the profiles of 279 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 65 | 23% |
| Spain | 26 | 9% |
| United Kingdom | 15 | 5% |
| France | 10 | 4% |
| Australia | 5 | 2% |
| Canada | 5 | 2% |
| Mexico | 5 | 2% |
| Belgium | 3 | 1% |
| Venezuela, Bolivarian Republic of | 2 | <1% |
| Other | 32 | 11% |
| Unknown | 111 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 165 | 59% |
| Scientists | 55 | 20% |
| Practitioners (doctors, other healthcare professionals) | 51 | 18% |
| Science communicators (journalists, bloggers, editors) | 8 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,646 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 2 | <1% |
| Brazil | 2 | <1% |
| United Kingdom | 2 | <1% |
| Austria | 1 | <1% |
| Czechia | 1 | <1% |
| Sweden | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 1635 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 256 | 16% |
| Student > Ph. D. Student | 180 | 11% |
| Other | 168 | 10% |
| Student > Master | 127 | 8% |
| Student > Bachelor | 117 | 7% |
| Other | 331 | 20% |
| Unknown | 467 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 608 | 37% |
| Biochemistry, Genetics and Molecular Biology | 176 | 11% |
| Immunology and Microbiology | 80 | 5% |
| Agricultural and Biological Sciences | 67 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 52 | 3% |
| Other | 114 | 7% |
| Unknown | 549 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1536. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#7,608
of 25,837,817 outputs
Outputs from New England Journal of Medicine
#399
of 32,687 outputs
Outputs of similar age
#94
of 330,579 outputs
Outputs of similar age from New England Journal of Medicine
#9
of 311 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,579 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 311 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.